triiodothyronine has been researched along with Adenocarcinoma, Papillary in 6 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of benign intracranial hypertension occurring during thyreostimulin suppression hormonotherapy after thyroidectomy for papillary cancer." | 1.31 | Benign intracranial hypertension and thyreostimulin suppression hormonotherapy. ( Conrath, J; Disdier, P; Dufour, H; Granel, B; Henry, JF; Serratrice, J; Weiller, PJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serratrice, J | 1 |
| Granel, B | 1 |
| Conrath, J | 1 |
| Dufour, H | 1 |
| Disdier, P | 1 |
| Henry, JF | 1 |
| Weiller, PJ | 1 |
| Majima, T | 1 |
| Doi, K | 1 |
| Komatsu, Y | 1 |
| Itoh, H | 1 |
| Fukao, A | 1 |
| Shigemoto, M | 1 |
| Takagi, C | 1 |
| Corners, J | 1 |
| Mizuta, N | 1 |
| Kato, R | 1 |
| Nakao, K | 1 |
| Fujimoto, Y | 1 |
| Ohara, T | 1 |
| Ito, Y | 1 |
| Sethi, VK | 1 |
| Fairclough, PD | 1 |
| Cryer, RJ | 1 |
| McAllister, J | 1 |
| Hawkins, L | 1 |
| Jones, AE | 1 |
| McKendrick, M | 1 |
| Hall, R | 1 |
| Besser, GM | 1 |
| Tesárek, T | 1 |
1 review available for triiodothyronine and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule.
Topics: Adenocarcinoma, Papillary; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Humans; Immunohisto | 2005 |
5 other studies available for triiodothyronine and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Benign intracranial hypertension and thyreostimulin suppression hormonotherapy.
Topics: Adenocarcinoma, Papillary; Drug Therapy, Combination; Female; Glycoproteins; Humans; Middle Aged; Pa | 2002 |
[Endocrine aspects of thyroid cancer].
Topics: Adenocarcinoma, Papillary; Adult; Aged; Calcitonin; Carcinoma; Female; Humans; Male; Middle Aged; Th | 1982 |
Non-surgical treatment of thyroid carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Carcinoma; Humans; Iodine Radioisotopes; Thyroid Neoplasm | 1981 |
Serum TSH responses to intravenously and orally administered TRH in man after thyroidectomy for carcinoma of the thyroid.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Administration, Oral; Adult; Aged; Female; Humans; Inject | 1973 |
An attempt at influencing thyroid carcinoma with hormones.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Animals; Humans; Male; Middle Aged; Thyroid | 1974 |